31-08-2013 t/m 4-09-2013 ESC Congres 2013 Amsterdam (NH)

[oma]

On Monday, September 2nd, 72 cardiologists met in the setting of the Rijksmuseum to discuss the main challenges they see in the near future in Cardiology.

Interview with Professor Valentin Fuster - Cardiology Leadership Dialogue, Rijksmuseum.

[oma]

Four studies presented at the European Society of Cardiology Congress have further highlighted that there is still much to be learned about the connection between obesity and mortality risk.

To put the findings into perspective, we spoke with Prof. Diethelm Tschoepe of Germany, who moderated the session.

ESC13 Commentary: The Obesity Paradox

[oma]

On Monday, September 2nd, 72 cardiologists met in the setting of the Rijksmuseum to discuss the main challenges they see in the near future in Cardiology.

Interview with Dr Von Bardeleben - Cardiology Leadership Dialogue, Rijksmuseum.

[oma]

Neither saxagliptin nor alogliptin was associated with increased -- or decreased -- rates of major adverse cardiovascular events in high-risk patients with type 2 diabetes mellitus in separate randomized, double-blind, placebo-controlled trials.

Prof. Ulf Landmesser of University Hospital of Zürich sums up the implications of the two trials.

ESC13 Commentary: EXAMINE and SAVOR-TIMI 53 Trials

[oma]

ESC 2013 Hotline I Thrombosis Elliott Antman

[oma]

Een blog van het opperhoofd van het American College of Cardiology, prof. John Gordon Harold (Cedars-Sinai Heart Institute, Los Angeles).

As I prepare to leave the land of Rembrandt, Van Gogh, canals, windmills, tulips, wooden shoes – and for the last five days the global hub for all things cardiology – I can’t help but feel proud of our profession and the continued strides were are making to improve the cardiovascular health of the global population.

I’m always impressed by the annual European Society of Cardiology (ESC) Congress and this year didn’t disappoint. The late-breaking clinical science broke new ground in a number of areas, and in some cases could change the way we manage care or even run clinical trials. I even had the honor of chairing the “Late Breaking Trials on Risk Factors and Diabetes” on Monday.

- See more at: http://blog.cardiosource.org/post/esc-congress-2013-thats-a-wrap/#sthash.QtJRTU37.dpuf

[oma]

On Monday, September 2nd, 72 cardiologists met in the setting of the Rijksmuseum to discuss the main challenges they see in the near future in Cardiology.

Interview with Professor Simon Matskeplishvili - Cardiology Leadership Dialogue, Rijksmuseum.

Cardiology Leadership Dialogue at the Rijksmuseum

[oma]

Cardiology News reporter, Bruce Jancin, brings you some of the highlights of the 2013 ESC Congress in Amsterdam -- from bikes to practice-changing studies

ESC13 Reporter's Notebook: ESC Congress 2013 Wrap Up

[oma]

Mariell Jessup, MD discusses the highlights of the late breaking clinical trials presented for Hot Line IV on Heart Failure and Acute Coronary Syndrome during the European Society of Cardiology Congress 2013 in Amsterdam.

ESC 2013 Amsterdam all

[oma]

Mariell Jessup, MD, discusses EchoCRT and BIC-9 which were presented at the European Society of Cardiology Congress 2013

EchoCRT, BIC-8--ESC Congress 2013 Heart Failure and ACS